Current Environment: Production

Martha Fishman | Education

Undergraduate School

Yale University

1984, New Haven, CT

Medical School

Harvard Medical School

1988, Boston, MA

Internship

Pediatrics

Boston Children's Hospital

1989, Boston, MA

Residency

Pediatrics

Boston Children's Hospital

1991, Boston, MA

Fellowship

Pulmonary Medicine

Boston Children's Hospital

1994, Boston, MA

Martha Fishman | Certifications

  • American Board of Pediatrics (Pulmonology)

Martha Fishman | Professional History

Dr. Fishman serves as an expert for the Department of Pulmonary Medicine for Boston Children's Hospital Precision Medicine Service. For more information about the Precision Medicine Service please visit bostonchildrens.org/precisionmed.

Martha Fishman | Publications

  1. A progranulin variant causing childhood interstitial lung disease responsive to anti-TNF-a biologic therapy. Med. 2025 Feb 25; 100607. View A progranulin variant causing childhood interstitial lung disease responsive to anti-TNF-a biologic therapy. Abstract

  2. Severe Features of Systemic Juvenile Idiopathic Arthritis in Patients With Congenital Heart Disease. J Rheumatol. 2024 Aug 01; 51(8):811-817. View Severe Features of Systemic Juvenile Idiopathic Arthritis in Patients With Congenital Heart Disease. Abstract

  3. Approach to the patient with Childhood Interstitial and Diffuse Lung Disease. Pediatr Pulmonol. 2024 Sep; 59(9):2267-2275. View Approach to the patient with Childhood Interstitial and Diffuse Lung Disease. Abstract

  4. Development of a Screening Algorithm for Lung Disease in Systemic Juvenile Idiopathic Arthritis. ACR Open Rheumatol. 2023 Oct; 5(10):556-562. View Development of a Screening Algorithm for Lung Disease in Systemic Juvenile Idiopathic Arthritis. Abstract

  5. The US national registry for childhood interstitial and diffuse lung disease: Report of study design and initial enrollment cohort. Pediatr Pulmonol. 2024 Sep; 59(9):2236-2246. View The US national registry for childhood interstitial and diffuse lung disease: Report of study design and initial enrollment cohort. Abstract

  6. Incidence and Risk Factors for Eosinophilia and Lung Disease in Biologic-Exposed Children With Systemic Juvenile Idiopathic Arthritis. Arthritis Care Res (Hoboken). 2023 10; 75(10):2063-2072. View Incidence and Risk Factors for Eosinophilia and Lung Disease in Biologic-Exposed Children With Systemic Juvenile Idiopathic Arthritis. Abstract

  7. An intronic variant in TBX4 in a single family with variable and severe pulmonary manifestations. NPJ Genom Med. 2023 Mar 06; 8(1):7. View An intronic variant in TBX4 in a single family with variable and severe pulmonary manifestations. Abstract

  8. Signal Transducer and Activator of Transcription 5B Deficiency-associated Lung Disease. Am J Respir Crit Care Med. 2022 05 15; 205(10):1245-1250. View Signal Transducer and Activator of Transcription 5B Deficiency-associated Lung Disease. Abstract

  9. The role of pharmacy services beyond cystic fibrosis: A case for support in childhood interstitial lung disease. Pediatr Pulmonol. 2022 06; 57(6):1535-1536. View The role of pharmacy services beyond cystic fibrosis: A case for support in childhood interstitial lung disease. Abstract

  10. A homozygous stop-gain variant in ARHGAP42 is associated with childhood interstitial lung disease, systemic hypertension, and immunological findings. PLoS Genet. 2021 07; 17(7):e1009639. View A homozygous stop-gain variant in ARHGAP42 is associated with childhood interstitial lung disease, systemic hypertension, and immunological findings. Abstract

  11. Nonsurgical management of dynamic pneumatocele via endobronchial administration of fibrin sealant. Pediatr Pulmonol. 2021 10; 56(10):3425-3428. View Nonsurgical management of dynamic pneumatocele via endobronchial administration of fibrin sealant. Abstract

  12. Pulmonary manifestations of immune dysregulation in CTLA-4 haploinsufficiency and LRBA deficiency. Pediatr Pulmonol. 2021 07; 56(7):2232-2241. View Pulmonary manifestations of immune dysregulation in CTLA-4 haploinsufficiency and LRBA deficiency. Abstract

  13. Overview of the ChILD Research Network: A roadmap for progress and success in defining rare diseases. Pediatr Pulmonol. 2020 07; 55(7):1819-1827. View Overview of the ChILD Research Network: A roadmap for progress and success in defining rare diseases. Abstract

  14. Neuroendocrine Cell Hyperplasia of Infancy. Clinical Score and Comorbidities. Ann Am Thorac Soc. 2020 06; 17(6):724-728. View Neuroendocrine Cell Hyperplasia of Infancy. Clinical Score and Comorbidities. Abstract

  15. Emergent high fatality lung disease in systemic juvenile arthritis. Ann Rheum Dis. 2019 12; 78(12):1722-1731. View Emergent high fatality lung disease in systemic juvenile arthritis. Abstract

  16. Pediatric Hemoptysis without Bronchiectasis or Cardiac Disease: Etiology, Recurrence, and Mortality. J Pediatr. 2019 11; 214:66-70. View Pediatric Hemoptysis without Bronchiectasis or Cardiac Disease: Etiology, Recurrence, and Mortality. Abstract

  17. Pulmonary hemorrhage in infancy: A 10-year single-center experience. Pediatr Pulmonol. 2018 11; 53(11):1559-1564. View Pulmonary hemorrhage in infancy: A 10-year single-center experience. Abstract

  18. Current Update on Interstitial Lung Disease of Infancy: New Classification System, Diagnostic Evaluation, Imaging Algorithms, Imaging Findings, and Prognosis. Radiol Clin North Am. 2016 Nov; 54(6):1065-1076. View Current Update on Interstitial Lung Disease of Infancy: New Classification System, Diagnostic Evaluation, Imaging Algorithms, Imaging Findings, and Prognosis. Abstract

  19. Genotype-phenotype correlations for infants and children with ABCA3 deficiency. Am J Respir Crit Care Med. 2014 Jun 15; 189(12):1538-43. View Genotype-phenotype correlations for infants and children with ABCA3 deficiency. Abstract

  20. Swine-origin influenza a (H1N1) viral infection in children: initial chest radiographic findings. Radiology. 2010 Mar; 254(3):934-41. View Swine-origin influenza a (H1N1) viral infection in children: initial chest radiographic findings. Abstract

  21. Pancreatic lineage analysis using a retroviral vector in embryonic mice demonstrates a common progenitor for endocrine and exocrine cells. Int J Dev Biol. 2002 03; 46(2):201-7. View Pancreatic lineage analysis using a retroviral vector in embryonic mice demonstrates a common progenitor for endocrine and exocrine cells. Abstract

BESbswy